News & Updates

Thyroid hormones play a significant role in pancreatic endoderm cell (PEC) therapy in patients with type 1 diabetes (T1D), according to a study, noting that a thyroid hormone adjuvant therapy may be helpful in improving cell outcomes in some recipients of PEC.

Among individuals with type 2 diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) does not contribute to increased pancreatic cancer risk, according to a study.

A voice-based conversational artificial intelligence application helps type 2 diabetes (T2D) patients navigate basal insulin titration at home and, in turn, achieve rapid glycaemic control, as reported in a study.